TrialNeuro-oncology2011

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.

Nicholas Butowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.